You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HLA-matched donor

Showing 1 - 25 of 7,555
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Severe Aplastic Anemia Trial (Busulfan, Flu/Cy/ATG or Cy/ATG)

Not yet recruiting
  • Severe Aplastic Anemia
  • (no location specified)
Oct 1, 2023

Myeloid Malignancies, Lymphoid Malignancies Trial in Durham (NK Cell enriched-DLI only, NK-DLI + DUK-CPG-001)

Recruiting
  • Myeloid Malignancies
  • Lymphoid Malignancies
  • NK Cell enriched-DLI only
  • NK-DLI + DUK-CPG-001
  • Durham, North Carolina
    Duke University Health System
Mar 8, 2022

GVHD Trial (Grafalon, Thymoglobulin)

Not yet recruiting
  • GVHD
  • (no location specified)
Oct 9, 2023

Acute Leukemia, Acute Lymphocytic Leukemia, Acute Myelogenic Leukemia Trial (Haploidentical hematopoietic cell transplantation

Not yet recruiting
  • Acute Leukemia
  • +4 more
  • Haploidentical hematopoietic cell transplantation (haploHCT)
  • matched unrelated donor hematopoietic cell transplantation (MUD-HCT)
  • (no location specified)
Jul 13, 2022

Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial (drug, radiation, procedure)

Not yet recruiting
  • Acute Leukemia
  • +4 more
  • (no location specified)
Oct 18, 2022

Acute Myeloid Leukemia in Remission, MDS, Chronic Myeloid Leukemia in Remission Trial in Belgium (Thymoglobulin, Melphalan,

Recruiting
  • Acute Myeloid Leukemia in Remission
  • +9 more
  • Antwerp, Belgium
  • +9 more
Oct 5, 2021

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in New Hyde Park (radiation, drug,

Completed
  • Acute Lymphoblastic Leukemia
  • +5 more
  • Radiation
  • +3 more
  • New Hyde Park, New York
    Cohen Children's Medical Center
Apr 6, 2022

Severe Aplastic Anemia Trial in Atlanta (Fludarabine, Cyclophosphamide, Total Body Irradiation)

Recruiting
  • Severe Aplastic Anemia
  • Atlanta, Georgia
  • +1 more
Apr 4, 2022

Related Donors Donating PBSC to a Family Member, Healthy Donors, Acute Myelogenous Leukemia Trial in United States (MGTA-145,

Terminated
  • Related Donors Donating PBSC to a Family Member
  • +4 more
  • MGTA-145
  • Plerixafor
  • Duarte, California
  • +7 more
Apr 13, 2022

Hematologic Malignancy Trial in New York (melphalan, fludarabine, thiotepa)

Active, not recruiting
  • Hematologic Malignancy
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 21, 2022

Kidney Transplant Rejection Trial in Canada, United States (MDR-101)

Active, not recruiting
  • Kidney Transplant Rejection
  • MDR-101
  • La Jolla, California
  • +19 more
Aug 22, 2022

Hematologic Diseases Trial in Palo Alto (Allogeneic Stem Cell Transplant, CliniMACS TCR a/ß Reagent Kit and CliniMACS CD19)

Recruiting
  • Hematologic Diseases
  • Allogeneic Stem Cell Transplant
  • CliniMACS TCR α/β Reagent Kit and CliniMACS CD19
  • Palo Alto, California
    Lucile Packard Children's Hospital
Feb 2, 2022

SIOD With CKD Stage 3 Through 5, Cystinosis With CKD Stage 3 Through 5, FSGS With CKD Stage 3 Through 5 Trial in Palo Alto

Not yet recruiting
  • SIOD With CKD Stage 3 Through 5
  • +3 more
  • Cyclophosphamide 1200 mg/Kg
  • +8 more
  • Palo Alto, California
    Lucile Packard Children's Hospital
Aug 17, 2022

Multiple Myeloma, Amyloidosis Trial in Boston (drug, procedure, radiation)

Completed
  • Multiple Myeloma
  • Amyloidosis
  • Boston, Massachusetts
    Massachusetts General Hospital
Aug 24, 2021

Immune Tolerance Trial in Stanford (Hematopoietic cell transplantation, Total lymphoid irradiation)

Active, not recruiting
  • Immune Tolerance
  • Hematopoietic cell transplantation
  • Total lymphoid irradiation
  • Stanford, California
    Stanford University, School of Medicine
Jun 15, 2021

Acute Myeloid Leukemia, Advanced MDS Trial in New York (Busulfan, Melphalan, Fludarabine, Anti-Thymocyte Globulin, Palifermin,

Completed
Has Results
  • Acute Myeloid Leukemia
  • Advanced Myelodysplastic Syndromes
  • Busulfan, Melphalan, Fludarabine, Anti-Thymocyte Globulin, Palifermin, Stem cell transplant
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Aug 27, 2021

Immune Tolerance Trial in Palo Alto, Madison (Immune tolerance after kidney transplant, Donor blood stem cells and T cells)

Recruiting
  • Immune Tolerance
  • Immune tolerance after kidney transplant
  • Donor blood stem cells and T cells
  • Palo Alto, California
  • +1 more
Jul 15, 2020

Maternal KIR and Fetal HLA Influence Reproductive Success in

Recruiting
  • Reproductive Issues
  • Analysis combinations of maternal KIR and HLA-C genotypes
  • Madrid, Spain
    Instituto Valenciano de Infertilidad
Nov 30, 2022

Kidney Transplant Rejection Trial (MDR-103)

Not yet recruiting
  • Kidney Transplant Rejection
  • MDR-103
  • (no location specified)
Apr 4, 2022

Assess 7/8 HLA-matched Hematopoietic Stem Cell Transplantation

Completed
  • Stem Cell Transplantation
    • Princeton, New Jersey
      Local Institution
    Jun 13, 2022

    Viral Infections After HSCT Trial in Washington (VSTs)

    Active, not recruiting
    • Viral Infections After HSCT
    • VSTs
    • Washington, District of Columbia
      Childrens National Medical Center
    Aug 30, 2022

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Duarte, Atlanta (procedure, drug,

    Not yet recruiting
    • Acute Lymphoblastic Leukemia
    • +9 more
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +7 more
    • Duarte, California
    • +1 more
    Sep 22, 2023

    Severe Combined Immune Deficiency (SCID) Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)

    Enrolling by invitation
    • Severe Combined Immune Deficiency (SCID)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 24, 2022

    Predict T Cell Chimerism After MSD SCT for SCD?

    Recruiting
    • Sickle Cell Disease
    • Alemtuzumab Injection [Campath]
    • Amsterdam, Netherlands
      Amsterdam Medical Centre
    Jun 20, 2023

    Hematological Malignancies Trial in Belgium, Netherlands (Conditioning regimen: TBI + Fludarabine, Conditioning regimen:TLI (8

    Completed
    Has Results
    • Hematological Malignancies
    • Conditioning regimen: TBI + Fludarabine
    • Conditioning regimen:TLI (8 Gy) + ATG
    • Leuven, Flamish Brabant, Belgium
    • +10 more
    Nov 16, 2021